Skip to Content

Clinical Trials

Updated 11/9/10

General Sarcoma 

  • 2007-0395: (SARC 009): A Phase II Trial of Dasatinib in Advanced Sarcoma
  • 2008-0547: Ph III Trabectedin vs Dox (Doxorubicin) First Line in pts with TRS (Translocation-Related Sarcomas)
  • 2005-0524: Trabectedin for patients with Sarcoma chemo resistance.  ET743-SAR-3002
  • 2010-0191: Temsirolimus and IGF-1R Inhibitor for Sarcoma

Soft Tissue Sarcoma

  • 2007-0146: MPNST (Malignant Peripheral Nerve Sheath Tumor) (SARC 006) 

GIST

  • 2009-0296:  Ph. II ,non-randomized multicenter study of 5 year adjuvant Gleevec in patients at significant risk for recurrence following complete resection of primary GIST
  • 2008-0693: Ph III Nilotinib vs Imatinib unresectable/met GIST 

Ewing's Sarcoma

  • LAB08-0151: Tissue banking protocol- biomarkers predictive of response to targeted therapy

Supportive Care

  • 2008-0276: Mucositis: A Phase II study to evaluate the preliminary efficacy assessment of Caphosol in patients with sarcoma receiving multicycle chemotherapy with doxorubicin and ifosfamide or cisplatin
  • 2005-0099: Thrombocytopenia: Phase I/II Study of AMG 531 in Patients with Advanced Malignancy Receiving Treatment with Chemotherapy
  • 2009-0775: Nausea/Vomiting: -Dose/Schedule finding study of Palonosetron in Sarcoma patients receiving multi-day chemotherapy with adriamycin and ifosfamide (AI) 
  • 2008-0664: A Multicenter, Open-Label, Single-Arm Evaluation of Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Who Have Experienced CINV during the Previous Cycle of Low Emetogenic chemotherapy (LEC)
  • 2010-0438: Anemia: A Phase 1 Safety Study of LY2787106 in Patients with Cancer and Anemia

Related Diseases

Find Clinical Trials

Clinical trials are research studies that test new cancer drugs, diagnostic procedures and therapies on humans.


© 2014 The University of Texas MD Anderson Cancer Center